NCAM1 and myeloid sarcoma: In MS patients, Nait-Oumesmar et al. [56] reported an increase in PSA-NCAM+ progenitors in the SVZ, and in nearby lesions they detected PSA-NCAM+ cells that expressed the oligodendroglial markers, Olig2 and Sox10.